Log in to save to my catalogue

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angioge...

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angioge...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02345366v1

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

About this item

Full title

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Publisher

England: Nature Publishing Group [1987-....]

Journal title

Oncogene, 2019-02, Vol.38 (7), p.1050-1066

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group [1987-....]

More information

Scope and Contents

Contents

Vascular endothelial growth factor-A (VEGF-A) is highly subjected to alternative pre-mRNA splicing that generates several splice variants. The VEGF
and VEGF
b families encode splice variants of VEGF-A that differ only at the level of six amino acids in their C-terminal part. The expression level of VEGF
splice variants and their function a...

Alternative Titles

Full title

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_inserm_02345366v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02345366v1

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-018-0486-7

How to access this item